Omega Therapeutics Inc Asset Turnover Ratio (OMGA), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Omega Therapeutics Inc   (NASDAQ: OMGA)
 

Omega Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Omega Therapeutics Inc asset turnover ratio, the ability of Omega Therapeutics Inc 's assets to generate revenue in the third quarter 2024, increased sequentially to 0.12 in the third quarter (Sep 30 2024), OMGA's balance sheet remain strong.

Within sector 57 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2024 compared to the preceding quarter from 3019 to 3716.

Asset Turnover Ratio Definition



OMGA Asset Turnover Ratio (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Asset Change -58.94 % -53.21 % -50.4 % -31.93 % -35.15 %
Y / Y Revenue Change 214.32 % 181.16 % 357.36 % 34.6 % 39.66 %
Asset Turnover Ratio (TTM) 0.12 0.07 0.05 0.03 0.02
OMGA's Total Ranking # 3716 # 3019 # 3419 # 3497 # 3007
Seq. Asset Change -28.29 % -19.4 % -20.88 % -10.22 % -18.27 %
Seq. Revenue Change 22.4 % -9.58 % 138.87 % 18.89 % 9.49 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 58
Healthcare Sector # 561
Overall Market # 3716

Asset Turnover Ratio Statistics
High Average Low
0.05 0.02 0.01
(Sep 30 2024)   (Dec 31 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Gilead Sciences Inc   0.50 $ 28,299.000  Millions$ 56,630.250  Millions
Supernus Pharmaceuticals inc   0.50 $ 651.972  Millions$ 1,310.073  Millions
Bristol myers Squibb Company  0.50 $ 47,435.000  Millions$ 95,626.500  Millions
Halozyme Therapeutics Inc   0.49 $ 947.355  Millions$ 1,915.570  Millions
Globus Medical Inc   0.49 $ 2,478.596  Millions$ 5,027.383  Millions
Novocure Limited  0.49 $ 577.738  Millions$ 1,175.429  Millions
Fonar Corporation  0.49 $ 102.006  Millions$ 209.607  Millions
Sarepta Therapeutics Inc   0.49 $ 1,640.348  Millions$ 3,378.288  Millions
Ptc Therapeutics inc   0.48 $ 900.664  Millions$ 1,860.980  Millions
Collegium Pharmaceutical Inc   0.48 $ 597.801  Millions$ 1,236.525  Millions
Artivion Inc   0.48 $ 382.872  Millions$ 792.272  Millions
Intuitive Surgical Inc   0.48 $ 7,866.200  Millions$ 16,415.700  Millions
Vertex Pharmaceuticals Inc  0.48 $ 10,625.800  Millions$ 22,254.975  Millions
Ethema Health Corporation   0.48 $ 5.675  Millions$ 11.936  Millions
Orasure Technologies Inc  0.47 $ 222.802  Millions$ 470.208  Millions
Coherus Oncology inc   0.47 $ 304.340  Millions$ 643.251  Millions
Amphastar Pharmaceuticals Inc   0.47 $ 723.549  Millions$ 1,530.982  Millions
Mirum Pharmaceuticals Inc   0.47 $ 307.028  Millions$ 656.808  Millions
Twist Bioscience Corporation  0.47 $ 312.974  Millions$ 672.026  Millions
Lifeward ltd   0.46 $ 25.002  Millions$ 53.791  Millions
Cumberland Pharmaceuticals Inc   0.46 $ 36.785  Millions$ 79.638  Millions
Bgm Group Ltd  0.46 $ 24.115  Millions$ 52.567  Millions
Pulmonx Corporation  0.46 $ 77.865  Millions$ 170.598  Millions
23andme Holding Co  0.45 $ 191.889  Millions$ 422.590  Millions
Precision Biosciences Inc  0.45 $ 75.096  Millions$ 165.895  Millions
Catalent Inc   0.45 $ 4,422.000  Millions$ 9,832.000  Millions
Assertio Holdings inc   0.45 $ 125.763  Millions$ 280.957  Millions
Cervomed Inc   0.44 $ 13.194  Millions$ 30.011  Millions
Pacira Biosciences inc   0.44 $ 694.957  Millions$ 1,581.555  Millions
Ontrak Inc   0.44 $ 10.336  Millions$ 23.561  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.